Allelic Analysis of Serous Ovarian Carcinoma Reveals Two Putative Tumor Suppressor Loci at 18q22-q23 Distal to SMAD4, SMAD2, and DCC
- 31 July 2001
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 159 (1) , 35-42
- https://doi.org/10.1016/s0002-9440(10)61670-7
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Immunohistochemical Labeling for Dpc4 Mirrors Genetic Status in Pancreatic AdenocarcinomasThe American Journal of Pathology, 2000
- Transforming Growth Factor β Signal Transducer Smad2 Is Expressed in Mouse Meiotic Germ Cells, Sertoli Cells, and Leydig Cells During Spermatogenesis1Biology of Reproduction, 1999
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Localization of Human Cadherin Genes to Chromosome Regions Exhibiting Cancer-Related Loss of HeterozygosityGenomics, 1998
- Identification of Smad2, a Human Mad-related Protein in the Transforming Growth Factor β Signaling PathwayPublished by Elsevier ,1997
- MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal CarcinomaCell, 1996
- DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1Science, 1996
- Genetic alterations distinguish different types of ovarian tumorsInternational Journal of Cancer, 1995
- Mutations of the E–cadherin gene in human gynecologic cancersNature Genetics, 1994
- Identification of a Chromosome 18q Gene that Is Altered in Colorectal CancersScience, 1990